Trial Profile
Randomized Clinical Study for Pharmacokinetics and Pharmacodynamics Assessment of Drug Eritromax, Marketed by the Blausiegel Laboratory, Compared to Drug Eprex, Produced by Janssen-Cilag Laboratory, in Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Nov 2022
Price :
$35
*
At a glance
- Drugs Epoetin alfa (Primary)
- Indications Anaemia
- Focus Pharmacodynamics; Pharmacokinetics
- 04 Jul 2018 New trial record